| Dr Gerald M Kirshbaum, DDS | |
|
5400 Balboa Blvd, Suite 308, Encino, CA 91316-1502 | |
| (818) 788-8840 | |
| (818) 986-5502 |
| Full Name | Dr Gerald M Kirshbaum |
|---|---|
| Gender | Male |
| Speciality | Dentist - Pediatric Dentistry |
| Location | 5400 Balboa Blvd, Encino, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730205709 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223P0221X | Dentist - Pediatric Dentistry | 17110 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gerald M Kirshbaum, DDS 5400 Balboa Blvd, Suite 308, Encino, CA 91316-1502 Ph: (818) 788-8840 | Dr Gerald M Kirshbaum, DDS 5400 Balboa Blvd, Suite 308, Encino, CA 91316-1502 Ph: (818) 788-8840 |
News Archive
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Abacavir Sulfate Tablets, 60 mg. The NDA is based on the reference listed drug Ziagen® by ViiV Healthcare.
Researchers in Georgia State University's School of Public Health and Emory University's School of Medicine have received a $600,000 grant from the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality to help nursing homes implement practices to mitigate the impact of COVID-19 and stop the spread of the SARS-CoV-2 virus.
The prevalence of obesity and overweight in children in the region Västra Götaland in Sweden are stable, but there are signs that socioeconomic differences are increasing. These are the conclusions of a thesis presented at the Sahlgrenska Academy, University of Gothenburg, which has examined approximately 3,000 children aged 7-9 years in western Sweden.
Forest Laboratories Holdings Limited, a wholly owned subsidiary of Forest Laboratories, Inc. today announced that the company is acquiring exclusive rights in the United States for Saphris (asenapine) sublingual tablets, a treatment for adult patients with schizophrenia or acute bipolar mania, from Merck Sharp & Dohme B.V., a wholly owned subsidiary of Merck & Co., Inc.
› Verified 5 days ago
Dr. Lecia Erin Harmer, D.D.S., M.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 6345 Balboa Blvd Ste 314, Encino, CA 91316 Phone: 818-943-8228 Fax: 509-271-7372 | |
Jeremiah Beisel, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 15720 Ventura Blvd Ste 301, Encino, CA 91436 Phone: 818-788-7181 Fax: 818-907-1891 | |
Mr. Steven Yoshiharu Shiba, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 16311 Ventura Blvd, #1075, Encino, CA 91436 Phone: 818-783-2770 Fax: 818-788-0494 | |
Roya Delafraz, Dentist Medicare: Not Enrolled in Medicare Practice Location: 15760 Ventura Blvd Ste 606, Encino, CA 91436 Phone: 818-981-9143 | |
Dr. Jeffrey B Ballen, D.M.D Dentist Medicare: Medicare Enrolled Practice Location: 5363 Balboa Blvd, Suite 534, Encino, CA 91316 Phone: 818-986-6777 | |
Dr. Richard Lee Kahn, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 16406 Moorpark St, Encino, CA 91436 Phone: 213-740-8084 | |
Dr. Kory Michael Zussman, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 16311 Ventura Blvd Ste 625, Encino, CA 91436 Phone: 818-907-1318 |